Introduction
Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases caused by defects in the synthesis of the glycans of proteins and lipids, and in their attachment to these compounds (reviews in Freeze 2006; Grünewald 2007; Jaeken and Matthijs 2007) . At present, 42 types of CDG have been identified (Jaeken et al. 2009 ); they are mostly multisystem diseases and the number of symptoms and syndromes reported in CDG increases steadily. Although occasional patients with CDG and sensorineural deafness have been reported, deafness has not been observed as a consistent feature in any CDG. Recently, a defect was identified in RFT1 (Haeuptle et al. 2008 ) as a defect in the assembly part of the N-glycosylation pathway. RFT1 is involved in the transfer of Man 5 GlcNAc 2 -PP-Dol from the cytoplasmic side to the luminal side of the endoplasmic reticulum membrane, although it is not proven that it is the flippase itself (Frank et al. 2008; Rush et al. 2009 ). Recently, three other patients have been reported (Vleugels et al. 2009 ). We report two novel patients and conclude that all six known patients with this defect show a severe neurological syndrome including sensorineural deafness. In this paper, we use the novel CDG nomenclature, namely, the non-italicized gene symbol followed by -CDG, in this case RFT1-CDG (Jaeken et al. 2008 (Jaeken et al. , 2009 ).
Patients

Patient 1
Patient 1 is a boy of Moroccan descent, born of unrelated parents after a 36-week pregnancy by Caesarean section because of breech presentation. He has two healthy sisters. Birth weight was 1865 g, length 43 cm, and head circumference 31.5 cm. Apgar scores were 5 and 8. He showed retropulsion of the head, a stridorous inspiration, an important generalized (particularly axial) hypotonia, hypertonia of the finger flexors, hypokinesia, absent Moro reflex, normal glabellar reflex and brisk knee tendon reflexes. He had a rather small chin and a mildly limited extension of the elbows but no other dysmorphy. His eye movements were erratic with a tendency to internal strabismus. The further evolution was characterized by episodic apnoeas (necessitating several reanimations) and feeding difficulties (gastro-oesophageal reflux, difficult coordination between respiration and swallowing, relative constipation). The patient was partly fed via nasogastric tube. Epileptic seizures were easily controlled with valproic acid.
At the age of 8 months, weight was 3.87 kg (3rd centile is 7 kg), length 59.7 cm (3rd centile is 67 cm), and head circumference 39.5 cm (3rd centile is 43 cm). Psychomotor development was less than 4 weeks (he did not show eye contact) and there was no response to auditory stimuli. He had a tympanic abdomen; palpation of liver and spleen was normal.
Biochemical investigation Biochemical investigation showed normal blood count and normal levels of blood lactate, serum albumin, cholesterol, transaminases, creatine kinase, lactate dehydrogenase, arylsulfatase A, thyroid-stimulating hormone, total T 4 , thyroxinebinding globulin, insulin, growth hormone, IGF-1, and plasma amino acids. Blood clotting factor XI (14%; normal range for age 25-93%), protein C (11%; normal range for age 37-81%) and antithrombin (27%; normal range for age 52-128%) were decreased. Capillary zone electrophoresis showed a type 1 pattern of serum sialotransferrins.
Technical investigations Ultrasonography of liver, spleen and kidneys, echocardiography, ophthalmology, electromyography (EMG) (initially interpreted as myopathic), single-fibre EMG, sensory and motor nerve conduction velocities, and electroencephalography were normal. However, the brainstem evoked response audiometry (BERA) showed evidence for a severe bilateral hearing loss (no peak V at 80 dB) with normal tympanometry. Radiology of the skeleton showed no abnormalities. Brain MRI at the age of 3 weeks showed a cavum septum pellucidum but no other abnormalities, including normal myelination for age.
Patient 2
Patient 2, a girl, was born of Italian parents after a 36-week pregnancy with polyhydramnios. Apgar scores were only 1 and 5. Birth weight was 2490 g, length 44 cm, and head circumference 33 cm. There was no respiratory distress syndrome. Nevertheless, the patient had to be ventilated from birth and tracheostomy was performed at 4 months. There was facial dysmorphy (anteverted nostrils, depressed and broad nasal bridge, small mouth) as well as inverted nipples. Epilepsy started in the first week of life and was resistant to therapy. The newborn was extremely hypotonic and showed no spontaneous movements. She was never able to suck and swallow, and was fed by gastrostomy. Knee tendon reflexes were not elicitable. A femoral and iliac vein thrombosis was diagnosed at 4 months. At 11 months, weight was 8.87 kg (25th centile), length 66 cm (3rd centile is 67.6 cm) and head circumference 39 cm (3rd centile is 43.1 cm).
Biochemical investigations Biochemical investigations showed a normal metabolic screening except for a type 1 pattern of serum sialotransferrins on capillary zone electrophoresis. Blood coagulation factor XI was 11% (normal range for age 46-110%), antithrombin 17% (normal range 52-128%) and protein C 10% (normal range 31-83%).
Technical investigations Ultrasonography of liver, spleen and kidneys, echocardiography, electromyography, and motor and sensory nerve conduction velocities were normal. Radiology of the skeleton was normal. Ophthalmological investigation showed pale optic nerves. The electroencephalogram was epileptic without specific features. Brainstem evoked response audiometry showed severe bilateral hearing loss with normal tympanometry. Brain MRI showed symmetrical lesions of the basal ganglia, cortical atrophy, diffuse supratentorial white-matter hyperintensity, unmyelinated capsula interna, and normal cerebellum.
Methods
Lipid-linked oligosaccharide analysis (LLO) was carried out in fibroblasts as reported (Grubenmann et al. 2004) .
Mutation analysis of RFT1 gene was by direct sequencing of the RFT1 cDNA (Haeuptle et al. 2008 ). In the parents, carrier analysis was by sequencing of the corresponding exon at the genomic level.
Results
In controls, LLO analysis showed the formation of Glc 3 Man 9 GlcNAc 2 -PP-Dol, the fully assembled oligosaccharide precursor for N-glycosylation. However, LLO analysis revealed in both patients an accumulation of Man 5 GlcNAc 2 -PP-Dol, associated with a decreased formation of Glc 3 Man 9 GlcNAc 2 -PP-Dol.
Mutation analysis showed homozygosity in patient 1 for the previously reported missense mutation c.454A>G (p.K152E) and heterozygosity for this mutation in his parents. Patient 2 is compound heterozygous for two novel missense mutations affecting the same nucleotide: c.887T>A (p.I296K) and c.887T>G (p.I296R). Carrier analysis revealed heterozygosity for the c.887T>A mutation in the father and for the c.887T>G mutation in the mother. The isoleucine at position p.296 is perfectly conserved from humans over Drosophila melanogaster to Saccharomyces cerevisiae. Only in Rattus norvegicus and Mus musculus was a change to valine observed. However, no isoleucine-to-lysine or isoleucine-to-arginine variation was detected, pointing to the pathogenic character of both missense mutations. The two novel missense mutations are just like the other known RFT1 (missense) mutations predicted to be located in the luminal loops of the RFT1 protein.
Discussion
The present patients show a very similar, essentially neurological, clinical syndrome to the four other known patients with an RFT1 defect (Clayton and Grünewald 2009; Haeuptle et al. 2008; Imtiaz et al. 2000; Vleugels et al. 2009) . Common features are feeding problems, failure to thrive, severe developmental delay, poor to absent visual contact, epilepsy, hypotonia, and sensorineural deafness. Less-constant features are microcephaly, brisk tendon reflexes, variable dysmorphy, respiratory problems, gastrointestinal problems and venous thromboses. Except for sensorineural deafness, all these symptoms belong to the phenotype of a number of other CDG (reviews in Freeze 2006; Grünewald 2007; Jaeken and Matthijs 2007) . Sensorineural deafness has not been reported as a regular feature in any CDG type, although 42 different types have been described. In fact, it has been reported only rarely in CDG: in one patient with DIBD1-CDG CDG-IL (Kranz et al. 2007 ); in 1 of 10 patients with ATP6V0A2-CDG (cutis laxa type II) (Morava et al. 2008) ; in a few patients with severe PMM2-CDG (CDG Ia), the most frequent CDG (Imtiaz et al. 2000; Kjaergaard et al. 2001) ; and in one unsolved case (Hutchesson et al. 1995) . Deafness was not consistent between siblings affected with PMM2-CDG. This is possibly a chance association. Indeed, deafness is a relatively common disorder as about 1 in 800 children are born with serious permanent hearing impairment (Steel and Kros 2001) .
The fact that none of the other CDG is systematically associated with hearing loss may suggest that glycosylation is not particularly important for hearing, and/or that RFT1 may have a specific otoneurological function. Alternatively, the cytoplasmic accumulation of Man 5 GlcNAc 2 -PP-Dol or of a derivative of this compound may have an otoneurotoxic effect.
In conclusion, these data indicate that hearing loss belongs to the phenotype of RFT1-CDG, which in turn is the first CDG firmly associated with deafness in humans. With this novel symptom added to the already impressive list of signs and symptoms, CDG comes closely to 'It's all in it' (Jaeken 2003) , and therefore CDG should be included in the work-up of congenital, particularly syndromic, hearing loss. On the other hand, in unexplained, isolated deafness the possibility should be considered of a defect in otospecific glycosylation that is yet to be identified and is not detectable by isoelectrofocusing of serum transferrin.
